Recruiting
Intensive care
RecruitingEvaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness
Registered drugNo placebo
Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness
Registered drugNo placebo
- Disease:Intensive care
- Substances:Dalteparin SodiumEnoxaparin Sodium+3
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:Dalteparin Sodium
- Sponsor:Rigshospitalet



